baber/WOPTO huggingface dataset:
Patent EP-2255703-A1 (EP)
Inventor: DOERING RICHARD
IPC: A47F5/11
Filed: 2009-05-29
Abstract: The display (10) has a supporting structure comprising a wall (14) rotated around a rotation axis (A1) relative to another wall (12) during conversion from a transport position into a usage position. Trays (30-36) comprise a bending line (40) that runs in a tray level in the usage position. The tray is connected with the supporting structure using a connector e.g. locking strap and adhesive strap, in the transport position. The tray is supported in the usage position by the connector and two supporting points on a side of the bending line, which lies opposite to the connector. An independent claim is also included for a method for delivering and setting a goods stand-up display.
Patent EP-2110961-A1 (EP)
Inventor: LOEHR JOACHIM
IPC: H04J13/00
Filed: 2005-04-01
Abstract: Mobile terminal communicating resource requests for dedicated uplink channel resources in a mobile communication system. Further, it also relates to a method for communicating resource requests for dedicated uplink channel resources in a mobile communication system. To allow the serving cell to detect "DOWN" commands from non-serving cells during soft handover the invention suggests a new definition of criteria for setting the "happy bit" in the control information associated to data transmitted on dedicated uplink channels. According to these criteria the mobile terminal may not indicate an unhappy condition while ramping up resource utilization. Only if resources equivalent to the maximum serving grant are utilized, the transmission buffer status requires to and the power status of the terminal allows for the happy bit is set to indicate an unhappy condition.
Patent EP-2163712-A1 (EP)
Inventor: EIDE ROAR
IPC: E04H9/10
Filed: 2009-07-09
Abstract: A container tent for shelter of personnel or storage of equipment, particularly in combat areas, comprises an upper and lower horizontal container element (1, 2) foldably arranged by means of a support structure in the form of profiles (3) situated near outer edges of the upper and lower container element (1, 2). The container tent is  characterized in that  a vertical side element (4) for covering towards the surroundings between the upper and lower container element (1, 2) is formed by at least two layers of a strong fabric sheet mountable at a distance from each other to provide an open gap (5) between the respective fabric sheets, and that, after the mounting along the erected upper and lower container element (1, 2), the gap (5) in the vertical side element (4) between the respective fabric sheets is filled with gravel or other mass as to achieve sufficient ballistic properties.
Patent EP-2154185-A1 (EP)
Inventor: FRIEDRICH ANNE
IPC: C08J9/00
Filed: 2009-08-11
Abstract: Flame retardant polyurethane foam (A), comprises, as a flame retardant, a mixture of at least one halogen free polyarylphosphate compounds (I) and at least one halogen free monoarylphosphate compounds (II). Flame retardant polyurethane foam (A), comprises, as a flame retardant, a mixture of at least one halogen free polyarylphosphate compounds of formula (I) and at least one halogen free monoarylphosphate compounds of formula (II). R 1>-R 3>, R 5>-R 7>H, 1-4C alkyl or phenyl; R 4>H or 1-10C hydrocarbon radical; and n : 1-20. An independent claim is included for the preparation of (A) comprising reacting organic polyisocyanates with compounds containing at least two hydrogen atoms reactive towards isocyanates and known blowing agents, stabilizers, activators and/or other customary auxiliaries and additives at 20-80[deg] C, where the mixture of 0.1-40 parts of polyarylphosphate compounds (I) and 0.1-40 parts of monoarylphosphate compounds (II) based on 100 parts of polyol component, is used as flame retardant. [Image].
Patent EP-2289882-A1 (EP)
Inventor: MORENO BEATRIZ
IPC: A61K31/495
Filed: 2009-08-31
Abstract: New 3-oxopiperazinium derivatives agonists of Nerve Growth Factor and it use as medicaments. Neurotrophin binding to its specific receptor Trk A leads to the activation of multiple signalling cascades, culminating in neuroregenerative effects, including neuronal survival and neurite outgrowth. Neurotrophic factors have been used for the treatment of several neurodegenerative diseases. However, their use is limited by their inability to cross the blood-brain barrier, their short half life and their side effects. Small molecule neurotrophin peptidomimetics may be beneficial in treating a number of neurodegenerative disorders. The present invention shows the capacity of nerve growth factor agonist molecules derived from the 3-oxopiperazinium scaffold to induce differentiation in PC12 cells and, therefore, that these small molecules with NGF agonist activity may be beneficial for treatment of neurodegenerative diseases, due to their neuroregenerative effects.
Patent EP-2182056-A1 (EP)
Inventor: BAUER JOERG DR
IPC: C12N15/82
Filed: 2007-10-04
Abstract: New polynucleotides (A), encoding desaturases and elongases, comprise or are based on eight specific nucleotide sequences obtained from Ostreococcus lucimarinus (a species of algae). New polynucleotides (A) contain a nucleotide sequence selected from (a) sequences designated SEQ ID No. 1, 3, 5, 7, 9, 11, 13 or 15, (b) sequences encoding an aminoacid sequence designated SEQ ID No. 2, 4, 6, 8, 10, 12, 14 or 16, (c) sequences encoding a peptide having at least 80% homology with a peptide encoded by (a) or (b) and showing desaturase or elongase activity and (d) sequences of a fragment of (a), (b) or (c) which encodes a polypeptide showing desaturase or elongase activity. Independent claims are included for: (1) a vector (B) containing (A); (2) host cells containing (A) or (B); (3) the preparation of a polypeptide (C) with desaturase or elongase activity, by expressing (A) in a host cell and recovering (C) (encoded by (A)) from the cell; (4) the polypeptides (C) encoded by (A) or obtained by the above process; (5) antibodies which specifically recognize (C); (6) transgenic, non-human organisms containing (A), (B) or the transformed host cells; (7) the production of polyunsaturated fatty acids (PUFA's) or their derivatives of formula R 1-CO-(CH 2) n-(CH=CH-CH 2) m-(CH 2) p-CH 3 (I), by culturing the host cells or transgenic organisms under appropriate conditions for biosynthesis of (I); and (8) the production of an oil, lipid or fatty acid composition (D), involving formulating an appropriate material (I) obtained by the above process. R 1OH, coenzyme A (thioester), lysophosphatidyl-choline, lysophosphatidyl-ethanolamine, lysophosphatidyl-glycerol, lysodiphosphatidyl-glycerol, lysophosphatidyl-serine, lysophosphatidyl-inositol, sphingo-base or glyceryl residue of formula -OCH 2CH(OR 3)CH 2(OR 3); R 2H, lysophosphatidyl-choline, lysophosphatidyl-ethanolamine, lysophosphatidyl-glycerol, lysodiphosphatidyl-glycerol, lysophosphatidyl-serine, lysophosphatidyl-inositol, optionally unsaturated 2-24C alkylcarbonyl or -CO-(CH 2) n-(CH=CH-CH 2) m-(CH 2) p-CH 3; R 3H, optionally unsaturated 2-24C alkylcarbonyl or -CO-(CH 2) n-(CH=CH-CH 2) m-(CH 2) p-CH 3; n : 2-7 or 9; m : 2-6; p : 0 or 3. ACTIVITY : Cardiant; Cytostatic; Antidiabetic. MECHANISM OF ACTION : None given.
Patent EP-2186746-A1 (EP)
Inventor: MATSUOKA KENSUKE
IPC: B65D75/36
Filed: 2009-11-17
Abstract: Provision of a blister package that cannot be opened easily by infants, but can be opened easily, certainly and safely by a user when in use. A blister package 100 containing a blister 1 and a cover sheet 2, wherein the blister has a groove 3 formed in an outer edge section 1A thereof where the cover sheet is adhered and the groove 3 is free of adhesion of the sheet. The cover sheet is adhered to the outermost circumference 1a of the outer edge section 1A, the groove 3 is formed on the inward side of the outermost circumference 1a, and the cover sheet is not adhered to the area on the inward side of the groove 3.
Patent EP-2336310-A1 (EP)
Inventor: ACHKAR JIHANE
IPC: C12N9/88
Filed: 2009-12-16
Abstract: The present invention relates to a novel valencene synthase, to a nucleic acid encoding such valencene synthase, to a host cell comprising said encoding nucleic acid sequence and to a method for preparing valencene, comprising converting farnesyl diphosphate to valencene in the presence of a valencene synthase according to the invention.
Patent EP-2340812-A1 (EP)
Inventor: HOEEG-MOELLER CARSTEN
IPC: A61K9/16
Filed: 2009-12-18
Abstract: Disclosed are improved granular pharmaceutical preparations, together with improved methods and apparatus for preparation of granules for use in such preparations. Such methods are especially useful for making granules for solid oral dose pharmaceutical preparations, and are particularly suited to the production of granules comprising 5-aminosalicylic acid (5-ASA) for the treatment of inflammatory bowel disease. The granules exhibit a more sharply peaked length distribution, and hence aspect ratio distribution, and have a consequently much sharper dissolution profile after further processing.
Patent EP-2208922-A1 (EP)
Inventor: CHAN CHI MAN
IPC: F21V29/00
Filed: 2009-12-18
Abstract: The present invention relates to a LED lighting device, particularly to high power LED module assembly including a flex tube and the method for manufacturing the assembly. The flex tube includes a base engaging with each of the high power LED modules and a cover partially enclosing the base, wherein the cover is made by extrusion process such that, except for the bottom of the heat sink exposed to ambient environment, the base, the high power LED module and other portions of the heat sink are enclosed by and hermetically engaged with the cover. With such configuration of the present invention, not only the heat dissipating property of the LED module assembly is enhanced but also the waterproof property thereof is further improved, thereby considerably extending the service life of the LED module assembly.
Patent EP-2210542-A1 (EP)
Inventor: JANE SANTAMARIA MANUEL
IPC: A47J27/04
Filed: 2009-12-30
Abstract: This device comprising a steam generator, a cooking and blending container that receives the steam and contains a basket to contain food with holes in its bottom, the container is sealed with a cover, and has a rotating blade at the bottom to blend the food. Is characterised by the fact that the cooking enclosure has an orifice in its side to receive the steam, which moves down through the basket and when it has gone through the holes at the bottom, it rises through the basket to exit through an angular recess at the edge of the cover. The basket is supported on it periphery on the cooking enclosure.
Patent EP-2235752-A1 (EP)
Title: Composants luminescents a structure heterogene a hautes performances et procedes
Inventor: RYU YUNGRYEL
IPC: H01L33/28
Filed: 2009-01-06
Abstract: L'invention concerne un composant luminescent à structure hétérogène stratifiée comprenant au moins un substrat, une région de couche de placage en semiconducteur à base de nitrure de gallium de type N, une région de couche de placage en semiconducteur à base de nitrure de gallium de type P, une région de couche d'injection de trous à base d'oxyde de zinc de type P et une région de couche de contact ohmique. En variante, le composant peut également comprendre une région de couche de couronnement ou peut également comprendre une région de couche réfléchissante et une région de couche de couronnement de protection. Le composant peut également comprendre une ou plusieurs couches d'insertion enterrées voisines de la région de couche de contact ohmique. La région de couche de contact ohmique peut comprendre des matériaux tels que l'oxyde d'indium-étain, l'oxyde de gallium-étain ou un matériau à base d'oxyde d'indium-étain. Une pastille d'électrode N est formée et celle-ci est en contact électrique avec la région de couche de placage en semiconducteur à base de nitrure de gallium de type N. Une pastille de type P est formée et celle-ci est en contact électrique avec la région de type P.
Patent EP-2245014-A1 (EP)
Inventor: ECKHARDT MATTHIAS
IPC: A61K31/55
Filed: 2009-02-10
Abstract: La présente invention concerne des composés répondant à la formule (I), dans laquelle les groupes A, B, X, m, n et o sont tels que définis dans la revendication 1. Les composés présentent une activité pharmacologique très utile et sont, en particulier, des inhibiteurs de la 11 β-hydroxystéroïde déshydrogénase (HSD) de type 1. Ils sont donc appropriés pour le traitement et la prévention de maladies susceptibles d’être influencées par l’inhibition de cette enzyme, telles que des maladies métaboliques, en particulier le diabète de type 2, l’obésité et la dyslipidémie.
Patent EP-2242425-A1 (EP)
Inventor: FISCHER DANIEL
IPC: A61B8/08
Filed: 2009-01-21
Abstract: Die Mammographieanlage (2) zur Untersuchung einer Brust (10) umfasst eine Lagerplatte (12) und eine Kompressionsplatte (14,18) zwischen den die Brust (10) während einer röntgenographischen Untersuchung positioniert und komprimiert ist. Zur sonographischen Untersuchung der Brust (10) wird diese zwischen einem Ultraschallwandler (20) einerseits und der Lager- bzw. Kompressionsplatte (12,14) andererseits komprimiert. Die Brust wird dabei zur Aufnahme eines Sonographiebildes in unmittelbaren Kontakt mit dem Ultraschallwandler (20) gebracht.
Patent EP-2352310-A1 (EP)
Inventor: MARTINEZ IRANZO JOSE
IPC: H04R9/02
Filed: 2009-02-12
Abstract: The invention relates to an improved self-cooling loudspeaker of the electrodynamic type, formed by a magnetic circuit consisting of a cylindrical permanent magnet (1) and two polar parts (2 and 3), namely a cylindrical "core ring" (2) positioned on the permanent magnet (1) and a "return vessel" (3) haivng a circular plan view, on which the permanent magnet (1) is placed. The invention is essentially  characterized in that  the "core ring" (2) includes a plurality of helical grooves (4) on the outer cylindrical face thereof, while the "return vessel" (3) also includes a plurality of helical grooves (5) on the upper part of the inner cylindrical face thereof, matching the grooving (4) of the "corre ring" (2).
Patent EP-2255978-A1 (EP)
Inventor: MOROOKA NAOYUKI
IPC: B32B7/12
Filed: 2009-01-09
Abstract: Provided are a laminate having superior adhesion between a thermoplastic resin composition layer and rubber adhesive layer and superior durability in use, and a pneumatic tire comprising the laminate. This laminate comprises a thermoplastic resin composition layer and a rubber composition layer, wherein the thermoplastic resin composition layer comprises at least one selected from the group consisting of an ethylene-vinyl alcohol copolymer having an ethylene unit content of 20 to 50 mol%, an aliphatic polyamide having a molar ratio of methylene group to amide group of less than 5.4, and a meta-xylenediamine-adipic acid polycondensate; and wherein the rubber composition layer comprises 100 parts by weight of rubber component and 30 to 120 parts by weight of a wet-process silica having a BET specific surface area of 100 to 300 m 2 /g.
Patent EP-2346648-A1 (EP)
Inventor: KITAGAWA HIROKI
IPC: B25C1/00
Filed: 2009-10-13
Abstract: L'invention porte sur une machine à clouer (1) qui comprend un passage d'air (510) permettant une communication entre un vérin (200) et une chambre d'air de retour (500) dans laquelle est accumulé de l'air comprimé destiné à ramener un piston (300) à la position initiale. Le passage d'air (510) comporte une vanne de commande (520) commandant l'entrée de l'air comprimé, provenant du vérin (200), dans la chambre d'air de retour (500). La vanne de commande (520) ouvre le passage d'air (510) et permet l'entrée de l'air comprimé dans la chambre d'air de retour (500) dans le cas où l'objet cloué produit une faible force de réaction lors de l'enfoncement du clou, à savoir lorsque la distance de déplacement vers le haut du corps (100) par rapport au levier de poussée (700) est inférieure à une distance prédéterminée. L'air comprimé qui est entré dans la chambre d'air de retour (500) entre en outre dans une chambre située au-dessous du piston et sert d'amortisseur à air, ce qui permet une réduction de la force d'enfoncement.
Patent EP-2295563-A1 (EP)
Inventor: MATSUNAGA AKIKO
IPC: C12N1/15
Filed: 2009-04-21
Abstract: To provide novel β-amylase derived from a microorganism and a gene thereof. β-amylase derived from Bacillus flexus is provided.
Patent EP-2491544-A1 (EP)
Inventor: O'CONNOR DANIEL
IPC: G08G5/00
Filed: 2009-10-22
Abstract: L'invention concerne un système de communication aérienne (10) et un procédé correspondant, permettant de mettre en place un réseau de liaison de données entre des aéronefs participants (100), chaque aéronef participant (100) comprenant un transpondeur de liaison de données (12) qui permet d'envoyer et de recevoir des messages de communication standard (M) par le biais d'un protocole de communication standard ; ces transpondeurs de liaison de données (12) servent à mettre en place le réseau de liaison de données au moyen d'un protocole de communication standard, lesdits transpondeurs de liaison de données (12) transmettant des messages guidés par les événements (M) qui ont une structure prédéfinie qui les identifie en tant que messages d'essai (TM) et qui comprennent en même temps des données de message (MD) pour mettre en place le réseau de liaison de données. Ainsi, le réseau de liaison de données est uniquement mis en place par la transmission de messages (M) conformes audit protocole de communication standard.
Patent EP-2285893-A1 (EP)
Inventor: BAECKMAN MATS
IPC: C08L23/00
Filed: 2009-05-25
Abstract: The present invention deals with polymer compositions suitable for making pipes. The compositions comprise a multimodal copolymer of ethylene and one or more alpha-olefins having from 4 to 10 carbon atoms wherein the multimodal ethylene copolymer has a density of from 924 to 960 kg/m 3 , a melt index MFR 5  of from 0.5 to 6.0 g/10 min, a melt index MFR 2  of from 0.1 to 2.0 g/10 min and a shear thinning index SHI 2.7/210  of from 2 to 50. The compositions further have a level of volatile compounds of at most 100 ppm by weight and/or a homogeneity rating of at most 3. In addition the multimodal copolymer comprises: 
(A) from 35 to 60 % by weight, based on the combined amount of components (A) and (B), of a low molecular weight ethylene polymer selected from ethylene homopolymer and a copolymer of ethylene and one or more alpha-olefins having from 4 to 10 carbon atoms and having a weight average molecular weight of from 5000 to 100000 g/mol and a density of from 945 to 975 kg/m 3 ; and 
(B) from 40 to 65 % by weight, based on the combined amount of components (A) and (B), of a high molecular weight copolymer of ethylene and one or more alpha-olefins having from 4 to 10 carbon atoms and having a weight average molecular weight of from 100000 to 1000000 g/mol and a density of from 890 to 935 kg/m3.
Patent EP-2280903-A1 (EP)
Title: Équipement de distribution employant des débitmètres de coriolis
Inventor: GARRETT RYAN C
IPC: G01F1/84
Filed: 2009-06-03
Abstract: L'invention concerne un appareil de distribution de carburant liquide, comportant une pluralité de vannes d’arrivée, chacune reliée en ligne à une conduite d’arrivée respective en communication fluidique avec une source respective d’un carburant liquide particulier. Une pluralité de vannes de sortie est également installée, dont chacune est reliée en ligne à une conduite de sortie respective. Un flexible à carburant respectif est en communication fluidique avec chacune des conduites de sortie. L’appareil comporte en outre un débitmètre de Coriolis situé entre les vannes d’arrivée et les vannes de sortie, le débitmètre de Coriolis fournissant un signal de débit indicatif du débit qui le traverse. Un contrôleur a pour fonction de recevoir le signal de débit et de commander les vannes de telle sorte que des arrivées sélectionnées de carburants liquides particuliers soient distribuées à au moins un des flexibles à carburant. Selon un mode de réalisation représentatif, les arrivées sélectionnées de carburants liquides particuliers peuvent comprendre des carburants liquides individuels et des combinaisons mélangées de ceux-ci. Par exemple, les carburants liquides particuliers peuvent comprendre au moins deux des produits suivants : une essence d’un premier degré d’octane, une essence d’un deuxième degré d’octane, du carburant diesel, du biodiesel et de l’éthanol.
Patent EP-2387437-A1 (EP)
Inventor: DIUBALDI ANTHONY
IPC: A61N1/08
Filed: 2009-11-20
Abstract: A method and associated stimulation device for ensuring firing of an action potential in an intended physiological target activated by a stimulus pulse generated by an electrode of a non-invasive surface based stimulation device irrespective of skin-to-electrode impedance by: (i) increasing internal impedance of the stimulation device so as to widen a Chronaxie time period thereby ensuring firing of the action potential of the intended physiological target irrespective of the skin-to-electrode impedance; and/or (ii) generating a stimulation waveform that optimizes a non-zero average current (e.g., non-zero slope of the envelope of the stimulation waveform) during preferably substantially the entire current decay of the stimulus pulse.
Patent EP-2297180-A1 (EP)
Title: Peptides épitopes dérivés de mybl2 et vaccins les contenant
Inventor: TSUNODA TAKUYA
IPC: C07K7/06
Filed: 2009-06-09
Abstract: La présente invention concerne des vaccins peptidiques contre le cancer. En particulier, la présente invention concerne des peptides épitopes dérivés de MYBL2 qui élicitent les cellules T cytotoxiques (CTL). La présente invention concerne également des CTL établis qui reconnaissent spécifiquement les cellules cibles HLA-A24 positives pulsées avec les peptides. L’invention concerne également des cellules présentant l’antigène et des exosomes qui présentent l’un quelconque des peptides, ainsi que des méthodes d’induction de cellules présentant l’antigène. La présente invention concerne en outre des agents pharmaceutiques contenant les polypeptides dérivés de MYBL2 ou des polynucléotides codant pour ceux-ci, ainsi que des exosomes et des cellules présentant l’antigène comme principes actifs. En outre, la présente invention concerne des procédés permettant le traitement et/ou la prophylaxie (c’est-à-dire, la prévention) de cancers (tumeurs), et/ou la prévention de la récidive postopératoire de ceux-ci, ainsi que des méthodes permettant d’induire les CTL, des méthodes permettant d’induire une immunité anti-tumeur, en utilisant les polypeptides dérivés de MYBL2, des polynucléotides codant pour les polypeptides, des exosomes ou des cellules présentant l’antigène présentant les polypeptides, ou les agents pharmaceutiques de la présente invention. Les cancers à cibler comprennent entre autres la tumeur testiculaire, le cancer du pancréas, le cancer de la vessie, le cancer du poumon non à petites cellules, le cancer du poumon à petites cellules et le cancer de l’œsophage.
Patent EP-2296462-A1 (EP)
Inventor: LEVY RUTH
IPC: A01N33/02
Filed: 2009-06-12
Abstract: A method for modifying Parkinson's disease by periodically administering a pharmaceutical composition comprising a therapeutically effective amount of rasagiline or a pharmaceutically acceptable salt of rasagiline to the patient, thereby modifying the disease. The method includes reducing the rate of progression; delaying the need for symptomatic anti-Parkinsonian therapy; reducing the risk of a Parkinson's disease patient requiring symptomatic anti-Parkinsonian therapy; and reducing the functional decline.